# Calcium Channel Blocker in Myotonic Dystrophy Type 1

> **NCT07075965** · PHASE1 · NOT_YET_RECRUITING · sponsor: **University of Rochester** · enrollment: 20 (estimated)

## Conditions studied

- Myotonic Dystrophy 1

## Interventions

- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT07075965
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-07
- **Primary completion:** 2030-10-01
- **Final completion:** 2030-10-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07075965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07075965, "Calcium Channel Blocker in Myotonic Dystrophy Type 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07075965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*